Education
About Us
Working with TipRanks
Follow Us
Ss Innovations International, Inc (SSII)
:SSII
SSII Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.32 - $22.42
Previous CloseN/A
Volume157.00
Average Volume (3M)31.75K
Market Cap
$1.98B
Enterprise ValueN/A
Total Cash (Recent Filing)$405.77K
Total Debt (Recent Filing)$145.00K
Price to Earnings (P/E)―
Beta9.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding193,559,340
10 Day Avg. Volume88,302
30 Day Avg. Volume31,755
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
SS Innovations International News
PremiumCompany Announcements
SS Innovations Reports Surge in April 2025 Orders
PremiumCompany Announcements
SS Innovations Appoints Arvind Palaniappan as Interim CFO
PremiumCompany Announcements
SS Innovations Delays Annual Report Filing
PremiumCompany Announcements
SS Innovations Reports 2024 Achievements and Revenue Growth
PremiumCompany Announcements
SS Innovations Boosts Board and Advances Surgical Tech
PremiumCompany Announcements
SS Innovations Welcomes Surgical Robotics Pioneer, Launches SSI Mantra 3
PremiumCompany Announcements
SS Innovations Expands Board with Renowned Healthcare ExpertsPremiumCompany Announcements
SS Innovations Unveils Mantra-3 Surgical Robot---
SSII FAQ
What was Ss Innovations International, Inc’s price range in the past 12 months?
Ss Innovations International, Inc lowest stock price was $0.32 and its highest was $22.42 in the past 12 months.
What is Ss Innovations International, Inc’s market cap?
Ss Innovations International, Inc’s market cap is $1.98B.
When is Ss Innovations International, Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ss Innovations International, Inc’s earnings last quarter?
Currently, no data Available
Is Ss Innovations International, Inc overvalued?
According to Wall Street analysts Ss Innovations International, Inc’s price is currently Overvalued.
Does Ss Innovations International, Inc pay dividends?
Ss Innovations International, Inc does not currently pay dividends.
What is Ss Innovations International, Inc’s EPS estimate?
Ss Innovations International, Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ss Innovations International, Inc have?
Ss Innovations International, Inc has 193,559,340 shares outstanding.
What happened to Ss Innovations International, Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ss Innovations International, Inc?
Currently, no hedge funds are holding shares in SSII
---
SS Innovations International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
SSII Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $35.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
127.77%
12-Months-Change
Fundamentals
Return on Equity
-115.45%
Trailing 12-Months
Asset Growth
34.49%
Trailing 12-Months
Company Description
Ss Innovations International, Inc
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
---
Technical Analysis
Travere Therapeutics
―
Arcutis Biotherapeutics
―
Disc Medicine
―
Kymera Therapeutics
―
GoodRx Holdings
―
---